02 August 2018
Visiongain has launched a new pharma report Drug Delivery Technologies Market Report : Analysis of Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular and Nasal/Buccal Drug Delivery Technologies; Forecasts for Biologics, Vaccines and Major National Markets and Assessment of Leading Drug Delivery Companies
By definition, drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in the human body. In this report, the term drug delivery technology encompasses the methods of enhancing the delivery of a drug through changes in drug formulation, the use of medical devices or through combination products. Combination products are combinations of drug-device, biologic-device, biologic-drug or all three components together in one entity. Combination products will continue to provide promising approaches to the delivery of various types of drugs that may come with different molecular formulations in the coming years.
Drug delivery technologies also include drug delivery systems together with the various time delivery technologies that may be involved. Examples of drug delivery systems include tablets, capsules and patches. There are six main submarkets of drug delivery technologies that contribute to the total drug delivery technologies market — oral, inhalable, injectable/implantable, transdermal, ocular and nasal/buccal — each providing beneficial delivery routes for a specific small or large molecule towards an intended target.
The lead analyst for this report says:
“The market for drug delivery technologies has experienced strong growth in recent years. In 2018, the global drug delivery technologies market is expected to reach a value of $217.7bn. Visiongain expects the growth to continue over the forecast period. The market will be boosted by the increasing number of biologics as they are inherently difficult to administer by traditional drug delivery methods. Visiongain also expects the use of vaccines with innovative delivery platforms such as nasal sprays and transdermal patches will expand significantly over the next decade.
The US maintained its dominance as the leading national market for drug delivery technologies in 2018. Developed countries such as Japan, Germany and France were also key markets for drug delivery technologies in the same year. However, as these markets become more saturated with the growing number of drug delivery technologies, this presents opportunities for fast-growing markets such as China and India — which will become attractive areas of investment for big pharma companies.”
The Global market is highly competitive with many different players entering the market. The report discusses products from leading companies in the market. The report discusses products from leading companies in the market. Notable companies in the Drug Delivery Technology market include Alkermes, 3M, Skyepharma, Becton Dickinson and Company (BD), Antares Pharma, pSivida, Applied Pharma Research (APR), Ethypharm, Glycologic and NanoPass Technologies amongst others.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.
26 May 2022
The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.
19 April 2022
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet
13 April 2022
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.